During the past decade, Shin Nippon Biomedical Laboratories (SNBL) Inpatient Facility conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Shin Nippon Biomedical Laboratories (SNBL) Inpatient Facility" #1 collaborator was "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "PATH" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Shin Nippon Biomedical Laboratories (SNBL) Inpatient Facility" are "Salmonella" (1 trials) and "Shigella" (1 trials). Many other conditions were trialed in "Shin Nippon Biomedical Laboratories (SNBL) Inpatient Facility" in a lesser frequency.

Most popular intervention types in "Shin Nippon Biomedical Laboratories (SNBL) Inpatient Facility" are "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CVD 1208S, Challenge strain of wild-type Shigella flexneri 2a" (1 trials), "CVD 1902, a Salmonella enterica Serovar Paratyphi A live, oral vaccine" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Shin Nippon Biomedical Laboratories (SNBL) Inpatient Facility" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Shin Nippon Biomedical Laboratories (SNBL) Inpatient Facility". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Shin Nippon Biomedical Laboratories (SNBL) Inpatient Facility, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Shin Nippon Biomedical Laboratories (SNBL) Inpatient Facility, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".